Vitamin D Metabolism in Patients With Endocrine Disorders

PHASE1CompletedINTERVENTIONAL

Enrollment

261

Participants

Timeline

Start Date

April 16, 2019

Primary Completion Date

May 15, 2021

Study Completion Date

June 1, 2021

Conditions

Pituitary ACTH HypersecretionAcromegalyDiabetes Mellitus, Type 1Primary Hyperparathyroidism

Interventions

DRUG

Cholecalciferol 15000 UNT/ML Oral Solution

A single dose (150,000 IU) of cholecalciferol aqueous solution per os

Trial Locations (1)

Endocrinology Research Centre, Moscow, Moscow

All Listed Sponsors

collaborator

Russian Science Foundation

OTHER

lead

Endocrinology Research Centre, Moscow

OTHER_GOV

NCT04844164 - Vitamin D Metabolism in Patients With Endocrine Disorders | Biotech Hunter | Biotech Hunter